|
|
Webinar ArchiveWatch RTP Live on-demand videos and hear from our thought leaders on a variety of therapeutic areas. Below find a compilation of live physician and nursing webinars and check back for more as we continue to post archives as they become available. To receive notifications of when new content is made available, subscribe to our email list. You may be asked to create an account to review the program. 2025 Physician Programs (CME/MOC accredited):15
MAR
Cases from the Community: Investigators Discuss the Optimal Clinical Care of Patients with HER2-Positive Gynecologic Cancers
Featuring perspectives from Dr Kathleen N Moore, Dr David M O’Malley and Dr Alessandro D Santin, moderated by Dr O’Malley. Published April 2025.
19
FEB
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Colorectal Cancer
Featuring perspectives from Dr Scott Kopetz and Dr Jeffrey Meyerhardt. Published March 2025.
14
FEB
What Clinicians Want to Know: Addressing Current Questions Related to the Management of Renal Cell Carcinoma
Featuring perspectives from Dr Thomas E Hutson, Dr Rana R McKay, Dr Sumanta Kumar Pal and Dr Tian Zhang, moderated by Dr Pal. Published March 2025.
13
FEB
What Clinicians Want to Know: Addressing Current Questions Related to Novel Treatment Approaches for Urothelial Bladder Cancer and Prostate Cancer
Featuring perspectives from Dr Terence Friedlander and Dr Matthew D Galsky, Dr Neeraj Agarwal and Dr Andrew J Armstrong, moderated by Dr Elisabeth I Heath. Published March 2025.
30
JAN
Practical Perspectives: Experts Review Actual Cases of Patients with Biliary Tract Cancers
Featuring perspectives from Prof John Bridgewater. Published February 2025.
24
JAN
What Clinicians Want to Know: Biomarker Assessment and Related Treatment Decision-Making for Patients with Colorectal Cancer
Featuring perspectives from Dr Arvind Dasari, Dr Christopher Lieu, Dr Van K Morris, Dr Jenny Seligmann and Prof Eric Van Cutsem, moderated by Dr Lieu. Published February 2025.
23
JAN
Teaching Cases from Investigators: The Application of Available Research to the Clinical Care of Patients with Hepatocellular Carcinoma
Featuring perspectives from Dr Anthony El-Khoueiry, Dr Richard S Finn, Dr Aiwu Ruth He and Dr Stacey Stein, moderated by Dr Stephen “Fred” Divers. Published February 12, 2025.
15
JAN
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in EGFR-Mutant Non-Small Cell Lung Cancer
Featuring perspectives from Dr Enriqueta Felip and Dr Helena Yu. Published February 5, 2025.
9
JAN
Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 3 of a 3-Part Series
Featuring perspectives from Dr Jennifer Woyach. Published January 29, 2025.
7
JAN
Oncology Q&A: Discussing Common Questions Posed by Patients with Metastatic Triple-Negative Breast Cancer
Featuring perspectives from Dr Lisa Carey and Dr Rita Nanda. Published January 24, 2025.
2024 Physician Programs (CME/MOC accredited):12
DEC
Rounds with the Investigators: Compelling Teaching Cases Focused on the Management of Metastatic Breast Cancer
Featuring perspectives from Dr Erika Hamilton, Dr Kevin Kalinsky, Dr Ian E Krop, Dr Joyce O’Shaughnessy and Dr Sara M Tolaney. Published January 10, 2025.
11
DEC
Rounds with the Investigators: Compelling Teaching Cases Focused on the Role of Endocrine-Based Therapy in the Management of Breast Cancer
Featuring perspectives from Dr Matthew P Goetz, Dr Sara A Hurvitz, Dr Komal Jhaveri, Dr Virginia Kaklamani and Dr Seth Wander. Published January 3, 2025.
10
DEC
Rounds with the Investigators: Compelling Teaching Cases Focused on the Management of HER2-Low and HER2-Ultralow Breast Cancer
Featuring perspectives from Dr Aditya Bardia, Prof Giuseppe Curigliano, Dr Hope S Rugo and Dr Antonio C Wolff. Published December 21, 2024.
6
DEC
What Clinicians Want to Know: Addressing Current Questions and Controversies Regarding the Role of CAR T-Cell Therapy and Bispecific Antibodies in the Management of Lymphoma
Featuring perspectives from Dr Jeremy S Abramson, Dr Jennifer Crombie, Prof Martin Hutchings, Dr Matthew Lunning and Dr Tycel Phillips, moderated by Dr Abramson. Published January 15, 2025.
6
DEC
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Acute Myeloid Leukemia
Featuring perspectives from Dr Alexander Perl, Dr Eytan M Stein, Dr Richard M Stone, Dr Eunice S Wang and Prof Andrew H Wei, moderated by Dr Stein. Published January 6, 2025.
6
DEC
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Myeloid Leukemia
Featuring perspectives from Prof Andreas Hochhaus, Dr Michael J Mauro and Dr B Douglas Smith, moderated by Dr Mauro. Published January 8, 2025.
6
DEC
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Myelofibrosis
Featuring perspectives from Dr Prithviraj Bose, Dr Angela Fleischman, Dr Andrew T Kuykendall and Dr Abdulraheem Yacoub, moderated by Dr Kuykendall. Published January 13, 2025.
6
DEC
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Multiple Myeloma
Featuring perspectives from Dr Sagar Lonial, Prof Philippe Moreau, Dr Robert Z Orlowski, Dr Noopur Raje and Dr Paul G Richardson, moderated by Dr Lonial. Published December 20, 2024.
6
DEC
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia
Featuring perspectives from Dr Farrukh T Awan, Dr Bita Fakhri, Dr Kerry A Rogers, Dr Jeff Sharman and Dr William G Wierda, moderated by Dr Sharman. Published December 18, 2024.
19
NOV
The Implications of Recent Datasets for the Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer
Featuring perspectives from Dr Edward B Garon and Dr Luis Paz-Ares. Published October 15, 2024.
18
NOV
Exploring the Current Management Paradigm for Patients with Metastatic Triple-Negative Breast Cancer
Featuring perspectives from Dr Priyanka Sharma and Dr Sara M Tolaney. Published December 4, 2024.
16
NOV
Cases from the Community: Integrating New Research Findings into Practice
Featuring perspectives from Dr Harry Paul Erba, Dr Edward B Garon, Dr Daneng Li, Dr Christopher Lieu, Dr Kathleen N Moore and Dr Stephen T Oh, moderated by Dr Stephen “Fred” Divers. Published December 13, 2024.
13
DEC
Oncology Q&A — Patient Education Resource: Clinical Experts Address Common Questions Posed by Patients with Metastatic Triple-Negative Breast Cancer
Featuring perspectives from Dr Lisa A Carey and Dr Rita Nanda. Published January 17, 2025.
5
NOV
Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 2 of a 3-Part Series
Featuring perspectives from Dr Nicole Lamanna. Published November 22, 2024.
31
OCT
Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities
Featuring perspectives from Dr Komal Jhaveri and Dr Hope S Rugo. Published November 18, 2024.
29
OCT
The Implications of Recent Datasets for the Current and Future Management of Lung Cancer — A Review of Information from ESMO Congress 2024 and Other Conferences
Featuring perspectives from Dr Suresh S Ramalingam and Dr Gregory J Riely. Published November 22, 2024.
26
OCT
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care
Featuring perspectives from Dr Sarah B Goldberg, Dr Brad S Kahl, Dr Sagar Lonial, Dr Joyce O’Shaughnessy, Dr Noopur Raje, Dr Joshua K Sabari, Dr Matthew R Smith, Dr Sonali M Smith, Dr Sandy Srinivas and Dr Seth Wander. Published November 15, 2024.
15
OCT
The Implications of Recent Datasets for the Current and Future Management of Gastrointestinal Cancers — An ESMO Congress 2024 Review
Featuring perspectives from Dr Tanios Bekaii-Saab and Dr Philip A Philip. Published November 5, 2024.
8
OCT
Improving Outcomes with First-Line Endocrine-Based Therapy for Patients with HR-Positive, HER2-Negative Metastatic Breast Cancer
Featuring perspectives from Prof Francois-Clement Bidard and Dr Kevin Kalinsky. Published November 1, 2024.
26
SEP
The Implications of Recent Datasets for the Current and Future Management of Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review
Featuring perspectives from Dr Jacob Sands. Published October 22, 2024.
25
SEP
Practical Perspectives: Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell Lymphoma
Featuring perspectives from Dr Tycel Phillips and Dr Michael Wang. Published October 29, 2024.
24
SEP
Practical Perspectives: Optimizing Diagnosis and Treatment for Patients with Desmoid Tumors
Featuring perspectives from Dr Thierry Alcindor and Dr Mrinal Gounder. Published October 18, 2024.
17
SEP
Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 1 of a 3-Part Series
Featuring perspectives from Dr Matthew S Davids. Published October 10, 2024.
12
SEP
The Implications of Recent Datasets for the Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer
Featuring perspectives from Dr Edward B Garon and Dr Luis Paz-Ares. Published October 15, 2024.
11
SEP
The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with EGFR Mutations
Featuring perspectives from Dr Ibiayi Dagogo-Jack and Dr Corey J Langer. Published October 8, 2024.
10
SEP
The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR
Featuring perspectives from Dr Joshua K Sabari and Dr Helena Yu. Published October 1, 2024.
4
SEP
Data + Perspectives: Clinical Investigators Discuss the Current and Future Management of Diffuse Large B-Cell Lymphoma
Featuring perspectives from Dr Christopher Flowers, Prof Grzegorz S Nowakowski and Dr Laurie H Sehn, moderated by Dr Flowers. Published October 9, 2024.
4
SEP
Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Featuring perspectives from Dr Joshua Brody, Dr Matthew Lunning and Dr Jason Westin, moderated by Dr Lunning. Published October 4, 2024.
29
AUG
Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors
Featuring perspectives from Dr Pamela Kunz and Dr Simron Singh. Published September 17, 2024.
21
AUG
Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers
Featuring perspectives from Dr Tanios Bekaii-Saab and Dr John Strickler. Published September 11, 2024.
18
JUL
Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer
Featuring perspectives from Prof Solange Peters and Prof Ben Solomon. Published August 20, 2024.
17
JUL
Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
Featuring perspectives from Prof Peter Schmid and Dr Sara M Tolaney. Published September 6, 2024.
10
JUL
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers
Featuring perspectives from Dr Evan J Lipson. Published August 8, 2024.
9
JUL
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
Featuring perspectives from Dr Jesús G Berdeja and Dr Thomas Martin. Published August 9, 2024.
25
JUN
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology
Featuring perspectives from Dr Dana M Chase. Published July 26, 2024.
20
JUN
What Clinicians Want to Know About the Management of Triple-Negative Breast Cancer
Featuring perspectives from Dr Kevin Kalinsky and Dr Heather McArthur. Published July 10, 2024.
19
JUN
Investigator Perspectives on Available Research and Challenging Questions in Renal Cell Carcinoma: A Post-ASCO Annual Review
Featuring perspectives from Dr Rana R McKay and Prof Thomas Powles. Published July 17, 2024.
18
JUN
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer
Featuring perspectives from Dr Matthew Gubens. Published July 30, 2024.
11
JUN
Investigator Perspectives on Available Research and Challenging Questions in Melanoma and Nonmelanoma Skin Cancers: A Post-ASCO 2024 Annual Review
Featuring perspectives from Dr Nikhil I Khushalani and Dr Jason J Luke. Published July 19, 2024.
4
JUN
RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma
Featuring perspectives from Dr Joshua Brody, Dr Ian W Flinn and Dr Tycel Phillips. Published July 12, 2024.
3
JUN
RTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal Cancer
Featuring perspectives from Dr Scott Kopetz and Dr John Strickler. Published July 12, 2024.
3
JUN
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Metastatic Breast Cancer
Featuring perspectives from Dr Aditya Bardia, Dr Harold J Burstein, Prof Giuseppe Curigliano, Dr Sara A Hurvitz, Dr Hope S Rugo and Dr Joyce O’Shaughnessy, moderated by Dr Rugo. Published June 28, 2024.
2
JUN
Meet The Professors Live: Clinical Investigators Provide Perspectives on Actual Cases of Patients with Ovarian and Endometrial Cancer
Featuring perspectives from Dr Floor J Backes, Dr Mansoor Raza Mirza, Dr Ritu Salani, Dr Angeles Alvarez Secord and Dr Brian M Slomovitz, with cases presented by Dr Eric H Lee, Dr Priya Rudolph and Dr Lyndsay J Willmott, moderated by Dr Secord. Published June 26, 2024.
2
JUN
Breakfast with the Investigators: New Advances in Multiple Myeloma
Featuring perspectives from Dr Rafael Fonseca, Dr María-Victoria Mateos and Dr Elizabeth O’Donnell, moderated by Dr O’Donnell. Published July 8, 2024.
1
JUN
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Prostate Cancer
Featuring perspectives from Dr Neeraj Agarwal, Dr Emmanuel S Antonarakis, Dr Andrew J Armstrong, Dr Tanya B Dorff and Dr Matthew R Smith, moderated by Dr Armstrong. Published June 28, 2024.
1
JUN
Breakfast with the Investigators: Current and Emerging Role of Antibody-Drug Conjugates in the Treatment of Lung Cancer
Featuring perspectives from Dr Rebecca S Heist, Dr Luis Paz-Ares and Dr Jacob Sands, moderated by Dr Sands. Published July 2, 2024.
31
MAY
Second Opinion: Investigators Discuss How They Apply Available Clinical Research in the Care of Patients with Non-Small Cell Lung Cancer with an EGFR Mutation
Featuring perspectives from Dr Jonathan W Goldman, Dr Corey J Langer, Dr Joel W Neal, Dr Zofia Piotrowska, Dr Joshua K Sabari and Dr Helena Yu, moderated by Dr Yu. Published June 21, 2024.
31
MAY
Lunch with the Investigators: Hepatobiliary Cancers
Featuring perspectives from Dr Robin K (Katie) Kelley, Dr Edward Kim and Prof Arndt Vogel, and moderated by Dr Kelley. Published June 24, 2024.
14
MAY
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis
Featuring perspectives from Dr Aaron T Gerds. Published July 1, 2024.
8
MAY
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer
Featuring perspectives from Dr Justin F Gainor and Dr Karen Reckamp. Published June 11, 2024.
6
MAY
Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Urothelial Bladder Cancer
Featuring perspectives from Dr Matthew D Galsky and Dr Ashish M Kamat. Published June 7, 2024.
3
MAY
Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Prostate Cancer
Featuring perspectives from Dr Rahul Aggarwal, Dr Adam S Kibel, Dr Laurence Klotz and Dr Sandy Srinivas, moderated by Dr Elisabeth I Heath. Published May 29, 2024.
17
APR
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia
Featuring perspectives from Dr Naval Daver and Dr Courtney D DiNardo. Published May 13, 2024.
10
APR
Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer
Featuring perspectives from Prof Eric Van Cutsem. Published May 3, 2024.
3
APR
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series
Featuring perspectives from Dr Ruben A Mesa. Published May 1, 2024.
22
MAR
Third Annual National General Medical Oncology Summit
Featuring perspectives from 31 clinical investigators. Published April 19, 2024.
18
MAR
Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Endometrial Cancer
Featuring perspectives from Prof Nicoletta Colombo, Dr Matthew A Powell and Dr Brian M Slomovitz, moderated by Dr Shannon N Westin. Published April 30, 2024.
18
MAR
Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Ovarian Cancer
Featuring perspectives from Dr Joyce F Liu, Dr Mansoor Raza Mirza and Dr David M O’Malley, moderated by Dr Kathleen N Moore. Published April 12, 2024.
6
MAR
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer
Featuring perspectives from Dr Andrew J Armstrong and Dr Maha Hussain. Published March 27, 2024.
5
MAR
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer
Featuring perspectives from discussion from Prof Thierry André and Dr Arvind Dasari. Published April 5, 2024.
22
FEB
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer
Featuring perspectives from Dr Shilpa Gupta and Prof Thomas Powles. Published April 5, 2024.
15
FEB
Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review
Featuring perspectives from Dr Robin (Katie) Kelley and Dr Mark Yarchoan. Published March 20, 2024.
13
FEB
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma
Featuring perspectives from Dr Andrew M Evens and Dr Sonali M Smith. Published March 26, 2024.
8
FEB
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers
Featuring perspectives from Dr Yelena Y Janjigian and Dr Zev Wainberg. Published March 6, 2024.
6
FEB
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia
Featuring perspectives from Dr Lindsey Roeker and Dr Jeff Sharman. Published February 26, 2024.
1
FEB
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series
Featuring perspectives from Dr Stephen T Oh. Published March 8, 2024.
30
JAN
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer
Featuring perspectives from Dr Ian E Krop and Dr Priyanka Sharma. Published February 29, 2024.
26
JAN
Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Urothelial Bladder Cancer
Featuring perspectives from Dr Matthew Milowsky, Dr Peter H O’Donnell, Dr Jonathan E Rosenberg and Dr Arlene Siefker-Radtke, moderated by Dr Evan Y Yu. Published February 9, 2024.
25
JAN
Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Prostate Cancer
Featuring perspectives from Dr Rahul Aggarwal, Dr Emmanuel S Antonarakis, Dr Elisabeth I Heath and Dr A Oliver Sartor, moderated by Dr Alan H Bryce. Published February 19, 2024.
20
JAN
Consensus or Controversy? Investigator Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers
Featuring perspectives from Dr Ahmed Omar Kaseb and Prof Arndt Vogel. Published February 23, 2024.
19
JAN
Consensus or Controversy? Clinical Investigators Provide Perspectives on Biomarker Assessment and Related Decision-Making for Patients with Colorectal Cancer
Featuring perspectives from Dr Tanios Bekaii-Saab, Dr Andrea Cercek, Dr Cathy Eng and Dr John Strickler, moderated by Dr Christopher Lieu. Published February 14, 2024.
18
JAN
Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Gastroesophageal Cancers
Featuring perspectives from Dr David H Ilson, Dr Rutika Mehta, Dr Markus Moehler and Dr Manish A Shah, moderated by Dr Harry H Yoon. Published February 6, 2024.
11
JAN
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hormone Receptor-Positive Breast Cancer
Featuring perspectives from Dr Stephanie L Graff and Dr Erica Mayer. Published January 31, 2024.
9
JAN
Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 4 of a 4-Part Series
Featuring perspectives from Dr Bradley J Monk. Published February 16, 2024.
2023 Physician Programs (CME/MOC accredited):19
DEC
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series
Featuring perspectives from Dr Richard M Stone. Published January 16, 2024.
14
DEC
Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 3 of a 4-Part Series
Featuring perspectives from Dr Antonio González-Martín. Published January 23, 2024.
8
DEC
Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Multiple Myeloma
Featuring perspectives from Dr Amrita Krishnan, Dr Sagar Lonial, Dr Robert Z Orlowski, Dr Noopur Raje and Dr Paul G Richardson. Published January 9, 2024.
8
DEC
Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Chronic Lymphocytic Leukemia
Featuring perspectives from Dr Farrukh T Awan, Dr Matthew S Davids, Dr Stephen J Schuster, Dr William G Wierda and Dr Jennifer Woyach. Published January 2, 2024.
8
DEC
Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Diffuse Large B-Cell Lymphoma
Featuring perspectives from Prof Michael Dickinson, Dr Grzegorz S Nowakowski, Dr Gilles Salles, Dr Laurie H Sehn and Dr Jason Westin. Published January 5, 2024.
8
DEC
Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Follicular, Mantle Cell and Hodgkin Lymphoma
Featuring perspectives from Dr Jeremy S Abramson, Dr Stephen M Ansell, Dr Nancy L Bartlett, Dr Jonathon B Cohen, Dr Jonathan W Friedberg and Dr Brad S Kahl. Published December 26, 2023.
7
DEC
Beyond the Guidelines: Clinical Investigator Perspectives on the Management of HER2-Low Breast Cancer
Featuring perspectives from Dr Aditya Bardia, Dr Lisa A Carey, Dr Shanu Modi and Prof Peter Schmid. Published January 3, 2024.
6
DEC
Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Localized HER2-Negative Breast Cancer
Featuring perspectives from Dr Harold J Burstein, Dr Matthew P Goetz, Dr Sara A Hurvitz, Dr Joyce O’Shaughnessy and Dr Lajos Pusztai. Published December 27, 2023.
5
DEC
Beyond the Guidelines: Clinical Investigator Perspectives on the Management of ER-Positive Metastatic Breast Cancer
Featuring perspectives from Prof Francois-Clement Bidard, Dr Erika Hamilton, Dr Komal Jhaveri, Dr Virginia Kaklamani and Dr Hope S Rugo. Published December 20, 2023.
29
NOV
Inside the Issue: Targeted and Immunotherapeutic Approaches for Biliary Tract Cancers
Featuring perspectives from Dr Lipika Goyal and Dr Milind Javle. Published December 13, 2023.
16
NOV
Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 3 of a 3-Part Series
Featuring perspectives from Dr Samuel J Klempner. Published December 5, 2023.
14
NOV
Implications of Recent Data Sets for the Current and Future Management of Lung Cancer
Featuring perspectives from Dr Luis Paz-Ares, Dr Zofia Piotrowska and Dr David R Spigel. Published December 8, 2023.
9
NOV
Implications of Recent Data Sets for the Current and Future Management of Breast Cancer
Featuring perspectives from Dr Aditya Bardia and Dr Sara M Tolaney. Published November 29, 2023.
7
NOV
Implications of Recent Data Sets for the Current and Future Management of Gynecologic Cancers
Featuring perspectives from Dr Richard T Penson and Dr Krishnansu S Tewari. Published November 20, 2023.
26
OCT
Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2 of a 3-Part Series
Featuring perspectives from Prof Eric Van Cutsem. Published November 14, 2023.
24
OCT
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 2 of a 3-Part Series
Featuring perspectives from Dr Gail J Roboz. Published November 10, 2023.
17
OCT
Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 2 of a 4-Part Series
Featuring perspectives from Dr David M O’Malley. Published November 1, 2023.
14
OCT
Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
Featuring perspectives from a panel of 12 faculty. Published November 3, 2023.
7
OCT
Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research Institute
Featuring perspectives from a panel of 10 faculty. Published October 27, 2023.
3
OCT
Inside the Issue: Optimizing the Management of Nonmelanoma Skin Cancer
Featuring perspectives from Dr Nikhil I Khushalani and Dr Anna C Pavlick. Published October 24, 2023.
28
SEP
Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 1 of a 3-Part Series
Featuring perspectives from Dr Peter C Enzinger. Published October 20, 2023.
26
SEP
What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma
Featuring perspectives from Dr Toby A Eyre and Dr Brad S Kahl. Published October 18, 2023.
21
SEP
Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer
Featuring perspectives from Dr Jamie Chaft and Dr John V Heymach. Published October 13, 2023.
20
SEP
Practical Perspectives: Investigators Discuss Current Management and Actual Cases of Relapsed/Refractory Metastatic Colorectal Cancer
Featuring perspectives from Dr Kristen K Ciombor and Dr J Randolph Hecht. Published October 6, 2023.
19
SEP
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of a 3-Part Series
Featuring perspectives from Dr Naval Daver. Published October 20, 2023.
14
SEP
Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 1 of a 4-Part Series
Featuring perspectives from Dr Kathleen N Moore. Published October 9, 2023.
11
SEP
Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer
Featuring perspectives from Dr Hope S Rugo and Dr Tiffany Traina. Published September 29, 2023.
8
SEP
Cases from the Community: Investigators Discuss the Application of Available Research in the Care of Patients with Diffuse Large B-Cell Lymphoma
Featuring perspectives from Dr Matthew Lunning and Dr Laurie H Sehn, moderated by Dr Christopher R Flowers. Published October 12, 2023.
7
SEP
Consensus or Controversy? Documenting and Discussing Clinical Investigators’ Practice Patterns in Myelofibrosis
Featuring perspectives from Dr Prithviraj Bose and Dr Andrew T Kuykendall, moderated by Dr John Mascarenhas. Published October 4, 2023.
30
AUG
What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors
Featuring perspectives from Dr Nicole Lamanna and Dr William G Wierda. Published September 22, 2023.
10
AUG
Meet The Professor: Optimizing the Management of Melanoma
Featuring perspectives from Professor Georgina Long. Published September 11, 2023.
8
AUG
Inside the Issue: Optimizing the Management of Metastatic Pancreatic Cancer
Featuring perspectives from Dr Eileen O’Reilly and Dr Zev Wainberg. Published September 15, 2023.
2
AUG
Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
Featuring perspectives from Professor Martin Hutchings and Dr Loretta J Nastoupil. Published September 13, 2023.
31
JUL
Inside the Issue: Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer
Featuring perspectives from Dr Neal D Shore and Dr Mary-Ellen Taplin. Published September 1, 2023.
27
JUL
The Implications of Recent Data Sets for the Management of Hepatocellular Carcinoma
Featuring perspectives from Dr Ghassan Abou-Alfa and Dr Daneng Li. Published September 5, 2023.
25
JUL
Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 2 of a 2-Part Series
Featuring perspectives from Dr Richard F Riedel. Published August 29, 2023.
20
JUL
Inside the Issue: Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor
Featuring perspectives from Dr Adiyta Bardia and Dr Erika Hamilton. Published August 23, 2023.
18
JUL
Inside the Issue: Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management
Featuring perspectives from Dr Hans Lee and Dr Saad Zafar Usmani. Published August 22, 2023.
13
JUL
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers
Featuring perspectives from Dr Omid Hamid and Dr Evan J Lipson. Published August 16, 2023.
11
JUL
Inside the Issue: Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes
Featuring perspectives from Dr Guillermo Garcia-Manero and Dr David Sallman. Published August 1, 2023.
29
JUN
Inside the Issue: Optimizing the Management of Metastatic Urothelial Bladder Cancer
Featuring perspectives from Dr Terence Friedlander and Dr Petros Grivas. Published August 9, 2023.
28
JUN
The Implications of New Research Findings for the Management of Endometrial Cancer
Featuring perspectives from Dr Bradley J Monk and Dr Matthew A Powell. Published July 14, 2023.
15
JUN
Meet The Professor: The Current and Future Management of Hodgkin and Non-Hodgkin Lymphoma
Featuring perspectives from Dr Ian W Flinn. Published July 6, 2023.
6
JUN
Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Renal Cell Carcinoma
Featuring perspectives from Prof Laurence Albiges, Dr Toni Choueiri and Prof Thomas Powles, moderated by Dr Brian Rini. Published March 3, 2023.
5
JUN
Video Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Breast Cancer
Featuring perspectives from Dr Komal Jhaveri, Dr Kevin Kalinsky, Dr Ian E Krop, Dr Joyce O’Shaughnessy, Dr Hope S Rugo and Prof Peter Schmid, moderated by Dr Neil Love. Published June 23, 2023.
5
JUN
Breakfast with the Investigators: Urothelial Bladder Cancer
Featuring perspectives from Dr Matthew D Galsky, Prof Andrea Necchi and Dr Scott T Tagawa, moderated by Dr Neil Love. Published June 30, 2023.
4
JUN
Breakfast with the Investigators: Ovarian Cancer
Featuring perspectives from Dr Philipp Harter, Dr David M O’Malley and Dr Shannon N Westin, moderated by Dr Neil Love. Published June 27, 2023.
4
JUN
Meet The Professors Live: Clinical Investigators Provide Perspectives on Actual Cases of Patients with Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma
Featuring perspectives from Dr John N Allan, Dr Shaji K Kumar, Dr Ann S LaCasce, Dr Sagar Lonial, Dr Loretta J Nastoupil and Dr Susan O’Brien, moderated by Dr Neil Love. Published July 3, 2023.
3
JUN
Second Opinion: Investigators Discuss How They and Their Colleagues Apply Available Clinical Research in the Care of Patients with Prostate Cancer
Featuring perspectives from Dr Emmanuel S Antonarakis, Prof Karim Fizazi, Dr Rana R McKay, Dr Alicia K Morgans and Dr A Oliver Sartor, moderated by Dr Neil Love. Published July 11, 2023.
3
JUN
Breakfast with the Investigators: Hepatobiliary Cancers
Featuring perspectives from Dr Anthony El-Khoueiry, Dr Robin K (Katie) Kelley and Prof Arndt Vogel, moderated by Dr Neil Love. Published June 28, 2023.
2
JUN
Video Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Non-Small Cell Lung Cancer
Featuring perspectives from Dr Edward B Garon, Dr John V Heymach, Dr Corey J Langer, Dr Ticiana Leal, Dr David R Spigel and Dr Helena Yu, moderated by Dr Neil Love. Published June 20, 2023.
2
JUN
Lunch with the Investigators: Gastroesophageal Cancers
Featuring perspectives from Dr Yelena Y Janjigian, Dr Manish A Shah and Dr Harry H Yoon, moderated by Dr Neil Love. Published July 12, 2023.
23
MAY
Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 1 of a 2-Part Series
Featuring perspectives from Dr Brian Van Tine. Published June 16, 2023.
23
MAY
Beyond The Guidelines: Urologic Oncology Investigators Provide Perspectives on the Optimal Management of Prostate Cancer
Featuring perspectives from Dr Himisha Beltran, Dr Stephen J Freedland, Dr Fred Saad and Dr Neal D Shore, moderated by Dr Matthew R Smith. Published May 23, 2023.
19
MAY
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hepatobiliary Cancers
Featuring perspectives from Drs Ghassan Abou‑Alfa and Richard S Finn. Published May 19, 2023.
18
MAY
Meet The Professor: Optimizing the Management of Colorectal Cancer — Part 3 of a 3-Part Series
Featuring perspectives from Dr Michael J Overman. Published June 7, 2023.
4
MAY
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hepatobiliary Cancers
Featuring perspectives from Drs Ghassan Abou‑Alfa and Richard S Finn. Published May 19, 2023.
30
APR
Beyond The Guidelines: Urologic Oncology Investigators Provide Perspectives on the Optimal Management of Urothelial Bladder Cancer
Featuring perspectives from Prof Sia Daneshmand, Dr Joshua J Meeks, Dr Matthew Milowsky and Prof J Alfred Witjes, moderated by Dr Arlene Siefker‑Radtke. Published May 15, 2023.
30
APR
Beyond The Guidelines: Urologic Oncology Investigators Provide Perspectives on the Optimal Management of Prostate Cancer
Featuring perspectives from Dr Himisha Beltran, Dr Stephen J Freedland, Dr Fred Saad and Dr Neal D Shore, moderated by Dr Matthew R Smith. Published May 23, 2023.
19
APR
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer
Featuring perspectives from Drs Pashtoon M Kasi and Wells A Messersmith. Published May 8, 2023.
13
APR
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer
Featuring perspectives from Drs Luis Paz-Ares and Heather Wakelee. Published April 28, 2023.
12
APR
Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — Part 3 of a 3-Part Series
Featuring perspectives from Dr Sara A Hurvitz. Published April 26, 2023.
27
MAR
Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Endometrial Cancer
Featuring perspectives from Drs Robert L Coleman, Matthew A Powell and Brian M Slomovitz, moderated by Dr Shannon N Westin. Published April 25, 2023.
26
MAR
Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Ovarian Cancer
Featuring perspectives from Drs Mansoor Raza Mirza, Amit M Oza and Richard T Penson, moderated by Dr Joyce F Liu. Published April 13, 2023.
22
MAR
Meet The Professor: Optimizing the Management of Colorectal Cancer — Part 2 of a 3-Part Series
Featuring perspectives from Dr John Strickler. Published April 6, 2023.
20
MAR
Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Hepatobiliary Cancers
Featuring perspectives from Dr Richard Finn, Dr Lipika Goyal and Prof Arndt Vogel, moderated by Dr Katie Kelley. Published February 20, 2023.
19
MAR
Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Gastroesophageal Cancers
Featuring perspectives from Dr Yelena Janjigian, Prof Florian Lordick and Dr Zev Wainberg, moderated by Dr Samuel Klempner. Published February 20, 2023.
18
MAR
Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Colorectal Cancer
Featuring perspectives from Drs Tanios Bekaii-Saab, Scott Kopetz, and John Strickler and Prof Eric Van Cutsem, moderated by Dr Kristen Ciombor. Published February 20, 2023.
8
MAR
Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Gastroesophageal and Hepatobiliary Cancers — A 2023 Post-ASCO GI Webcast
Featuring perspectives from Drs Eric Lee, Neil Morganstein and Swati Vishwanathan. Published April 3, 2023.
7
MAR
Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — Part 2 of a 3-Part Series
Featuring perspectives from Dr Sara Tolaney. Published March 29, 2023.
6
MAR
Striving for Consensus on the Management of ALK-Positive Lung Cancer
Featuring perspectives from Dr D Ross Camidge, Dr Justin Gainor, Prof Benjamin Solomon and Prof Solange Peters. Published March 3, 2023.
4
MAR
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia and Myelodysplastic Syndromes
Featuring perspectives from Dr Uma Borate and Prof Andrew Wei. Published April 20, 2023.
2
MAR
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Renal Cell Carcinoma and Bladder Cancer
Featuring perspectives from Dr Matthew Milowsky and Prof Thomas Powles. Published April 14, 2023.
1
MAR
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer
Featuring perspectives from Drs Tanya Dorff and Oliver Sartor. Published April 5, 2023.
22
FEB
Meet The Professor: Optimizing the Management of Colorectal Cancer — Part 1 of a 3-Part Series
Featuring perspectives from Dr Christopher Lieu. Published March 13, 2023.
18
FEB
Recent Advances and Future Directions in Oncology: A Daylong Multitumor Educational Symposium in Partnership with the NCOA and the SCOS Joint Annual Conference
Proceedings from a daylong symposium held in partnership with the North Carolina Oncology Association and the South Carolina Oncology Society. Published March 17, 2023.
17
FEB
Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Urothelial Bladder Cancer
Featuring perspectives from Dr Matthew Galsky, Dr Jonathan Rosenberg and Dr Arlene Siefker-Radtke, moderated by Dr Elisabeth Heath. Published March 15, 2023.
16
FEB
Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Prostate Cancer
Featuring perspectives from Dr Emmanuel Antonarakis, Prof Karim Fizazi, Dr Maha Hussain and Dr Matthew Smith, moderated by Dr Alan Bryce. Published March 8, 2023.
15
FEB
Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Renal Cell Carcinoma
Featuring perspectives from Prof Laurence Albiges, Dr Toni Choueiri and Prof Thomas Powles, moderated by Dr Brian Rini. Published March 3, 2023.
8
FEB
Inside the Issue — Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer
Featuring perspectives from Drs Kathy Miller and Ann Partridge. Published March 7, 2023.
2
FEB
Inside the Issue — Optimizing the Management of Adverse Events Associated with BTK Inhibitors
Featuring perspectives from Drs Farrukh Awan and Kerry Rogers. Published February 23, 2023.
1
FEB
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hodgkin and Non-Hodgkin Lymphomas
Featuring perspectives from Drs Christopher Flowers and Laurie Sehn. Published February 17, 2023.
31
JAN
Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — Part 1 of a 3-Part Series
Featuring perspectives from Dr Komal Jhaveri. Published February 24, 2023.
26
JAN
Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 4 of a 4-Part Series
Featuring perspectives from Dr Noopur Raje. Published February 14, 2023.
24
JAN
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology
Featuring perspectives from Drs Michael Birrer and Kathleen Moore. Published February 8, 2023.
11
JAN
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer
Featuring perspectives from Drs Zofia Piotrowska and Gregory Riely. Published January 24, 2023.
10
JAN
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
Featuring perspectives from Drs Joseph Mikhael and Ajay Nooka. Published February 1, 2023
5
JAN
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia
Featuring perspectives from Drs Jennifer Brown and Deborah Stephens. Published January 20, 2023.
4
JAN
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Breast Cancer
Featuring perspectives from Dr Joyce O’Shaughnessy and Prof Peter Schmid. Published January 17, 2023.
Nursing Programs (CNE/NCPD, ILNA Accredited):1
MAY
What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Prostate Cancer
Featuring perspectives from Dr Andrew J Armstrong and Ms Brenda Martone. Published May 15, 2024.
27
APR
What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hepatobiliary Cancers
Featuring perspectives from Ms Blanca Ledezma, Dr Stacey Stein, Ms Amanda K Wagner and Dr Mark Yarchoan. Published May 22, 2024.
27
APR
What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Gastroesophageal and Colorectal Cancers
Featuring perspectives from Ms Deanna A Griffie, Ms Caroline Kuhlman, Dr Manish A Shah and Dr John Strickler. Published June 7, 2024.
27
APR
What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Myelofibrosis
Featuring perspectives from Ms Ilene Galinsky, Dr Andrew T Kuykendall, Dr Sara M Tinsley-Vance and Dr Abdulraheem Yacoub. Published June 5, 2024.
26
APR
What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Ovarian Cancer
Featuring perspectives from Ms Courtney Arn, Dr Floor J Backes, Dr Kathleen N Moore and Ms Jaclyn Shaver. Published June 3, 2024.
26
APR
What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Head and Neck Cancer
Featuring perspectives from Ms Meetal Dharia, Dr Robert L Ferris, Dr Robert Haddad and Ms Lynsey P Teulings. Published May 31, 2024.
26
APR
What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Non-Small Cell Lung Cancer with an EGFR Mutation
Featuring perspectives from Ms Marianne J Davies, Dr Alexander I Spira, Ms Jillian Thompson and Dr Helena Yu. Published May 10, 2024.
25
APR
What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Endometrial Cancer
Featuring perspectives from Ms Jennifer Filipi, Ms Kathryn Lyle, Dr David O’Malley and Dr Shannon N Westin. Published May 17, 2024.
25
APR
What I Tell My Patients: Integrating New Research Information into Clinical Care — CLL and Bispecific Antibodies in the Management of Lymphoma
Featuring perspectives from Dr John N Allan, Dr Brad S Kahl, Ms Robin Klebig and Ms Mollie Moran. Published June 14, 2024.
25
APR
What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Optimal Implementation of Antibody-Drug Conjugates
Featuring perspectives from Ms Jamie Carroll, Ms Kelly EH Goodwin, Dr Erika Hamilton and Dr Hope S Rugo. Published June 25, 2024.
24
APR
What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hormonal Therapy for Hormone Receptor-Positive Breast Cancer
Featuring perspectives from Dr Harold J Burstein, Ms Kelly Fischer, Dr Komal Jhaveri and Ms Melissa Rikal. Published June 19, 2024.
Please note that slides and other materials provided are for review only and not to be repurposed or published.
|